Article: New chromatography study findings have been reported by S.G. Delyle and colleagues.(Report)

New investigation results, 'Determination of rimonabant in human plasma and hair by liquid chromatography-mass spectrometry,' are detailed in a study published in Journal of Chromatography B. "Rimonabant is the first therapeutically relevant cannabinoid antagonist, licensed in Europe for treatment of obesity when a risk factor is associated. The objective of this study was to develop and validate a method for measurement of rimonabant in human plasma and hair using liquid chromatography coupled to mass spectrometry (LC-MS/MS)," scientists in Garches, France report (see also Chromatography).

"Rimonabant and AM-251 (internal standard) were extracted from 50 microL ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!